Advisor Group Holdings, Inc. Opti Nose, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.02 - $1.47 $1,530 - $2,205	1,500 New	1,500 $1,000
Q1 2022 May 04, 2022	SELL	$1.77 - $2.93 $3,009 - $4,981	-1,700 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$2.91 - $3.83 $363 - $478	-125 Reduced 6.85%	1,700 $6,000
Q1 2021 May 13, 2021	SELL	$3.47 - $4.75 $3,470 - $4,750	-1,000 Reduced 35.4%	1,825 $7,000
Q4 2020 Feb 10, 2021	SELL	$3.2 - $4.98 $1,600 - $2,490	-500 Reduced 15.04%	2,825 $11,000
Q3 2020 Nov 12, 2020	BUY	$3.69 - $7.09 $11,070 - $21,270	3,000 Added 923.08%	3,325 $13,000
Q2 2020 Aug 14, 2020	SELL	$3.58 - $7.44 $85 - $178	-24 Reduced 6.88%	325 $2,000
Q1 2020 May 18, 2020	BUY	$3.49 - $9.2 $1,218 - $3,210	349 New	349 $1,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $31.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.